Ardelyx, Inc. (ARDX) vs Lexicon Pharmaceuticals, Inc. (LXRX)
Ardelyx, Inc. and Lexicon Pharmaceuticals, Inc. are both Biotechnology companies. Ardelyx, Inc. and Lexicon Pharmaceuticals, Inc. are of similar size ($859.7M and $854.3M). Ardelyx, Inc. grew revenue faster over the last twelve months: 16.8% against −29.0%. Ardelyx, Inc. has the higher net margin (−12.4% vs −147.4%) and the higher return on invested capital (−18.6% vs −96.4%). Across the 18 metrics below, Ardelyx, Inc. leads on 12 and Lexicon Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | ARDX | LXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | 99.14% | 65.16% |
| Operating margin | (7.86%) | (131.43%) | 0.00% |
| Net margin | (12.35%) | (147.38%) | 0.00% |
| Free cash flow margin | (3.97%) | (156.71%) | 0.00% |
| Return on equity | (38.61%) | (40.21%) | (57.72%) |
| Return on assets | (10.68%) | (25.70%) | (49.22%) |
| Return on invested capital | (18.62%) | (96.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack